A Week to Remember for Women's Brain Foundation! Last week was nothing short of extraordinary for the Women's Brain Foundation.

Week 25-29 November, 2024

Here’s a recap of our eventful journey:

Swissmedic ‘Regulatory and Beyond’: Dr Antonella Santuccione Chadha proudly represented WBF at this prestigious event, where industry leaders discussed the latest developments, challenges, and future directions in drug regulation. The insights gained are reshaping our approach to R&D for more inclusive and personalized healthcare. 
Read more on LinkedIn

Webinar with EQUAL CARE: We joined forces with EQUAL CARE to highlight the critical importance of certifying for sex and gender precision medicine. Our collaborative effort aims to ensure trials are comprehensive and truly reflective of diverse populations. 📊
Read more on LinkedIn

Inspiring Talks: At the Women In Sustainable Finance International charity event, our board member Rosa Sangiorgio, alongside Afsaneh Nagy, Vanessa Gentile, and Dr. Marta Ra, shared personal stories and inspiring moments, advocating for women’s brain and mental health. Their powerful messages continue to resonate and inspire action. 
Read more on LinkedIn

 


Support the advancement of brain and mental health:

Donate today or with TWINT


We are here to transform medicine and healthcare towards precision medicine. Right now, there is a critical need for your support. Donate today and help us continue to study Sex and Gender differences impacting brain and mental diseases.

Health begins with human beings, individuals – men and women are different when it comes to brain and mental disease frequency, severity, symptomatology, risk factors and even response to treatments. Thanks to the gifts from supporters like you the scientific community is starting to take note. We have shown the world that in diseases like Alzheimer’s for instance, disease progression is faster in women than men and women show different levels of biomarkers.

Our goal is to clearly identify such differences in diseases, diagnostic, and treatments, as well as novel technologies, and leverage them for better solutions. We ask for better clinical outcomes, better care, and innovative artificial intelligence (AI)-based solutions. Sex and gender differences are the first steps towards precision medicine, which acknowledges the specific needs of each patient. Our ultimate ambition is the realisation of the Research Institute for Sex and Gender Precision Medicine.